6 results on '"Oliveira Gomes, Daniel Claudio"'
Search Results
2. Intranasal immunization with LACK-DNA promotes protective immunity in hamsters challenged with Leishmania chagasi
- Author
-
DE OLIVEIRA GOMES, DANIEL CLAUDIO, DA SILVA COSTA SOUZA, BEATRIZ LILIAN, DE MATOS GUEDES, HERBERT LEONEL, LOPES, ULISSES GAZOS, and ROSSI-BERGMANN, BARTIRA
- Published
- 2011
3. Effects of Bone Marrow Mesenchymal Stromal Cell Therapy in Experimental Cutaneous Leishmaniasis in BALB/c Mice Induced by Leishmania amazonensis.
- Author
-
Pereira, Joyce Carvalho, Ramos, Tadeu Diniz, Silva, Johnatas Dutra, de Mello, Mirian França, Pratti, Juliana Elena Silveira, da Fonseca-Martins, Alessandra Marcia, Firmino-Cruz, Luan, Kitoko, Jamil Zola, Chaves, Suzana Passos, De Oliveira Gomes, Daniel Claudio, Diaz, Bruno Lourenço, Rocco, Patricia R. M., and de Matos Guedes, Herbert Leonel
- Subjects
CUTANEOUS leishmaniasis ,MESENCHYMAL stem cells ,IMMUNOREGULATION ,CELLULAR therapy ,MACROPHAGES ,THERAPEUTICS - Abstract
Cutaneous leishmaniasis remains both a public health and a therapeutic challenge. To date, no ideal therapy for cutaneous leishmaniasis has been identified, and no universally accepted therapeutic regimen and approved vaccines are available. Due to the mesenchymal stromal cell (MSC) immunomodulatory capacity, they have been applied in a wide variety of disorders, including infectious, inflammatory, and allergic diseases. We evaluated the potential effects of bone marrow MSC therapy in a murine model of cutaneous leishmaniasis. In vitro, coculture of infected macrophages with MSC increased parasite load on macrophages in comparison with controls (macrophages without MSCs). In vivo, BALB/c mice were infected with 2 × 10
6 Leishmania amazonensis (Josefa strain) promastigotes in the footpad. 7 and 37 days after infection, animals were treated with 1 × 105 MSCs, either intralesional (i.l.), i.e., in the same site of infection, or intravenously (i.v.), through the external jugular vein. Control animals received the same volume (50 µL) of phosphate-buffered saline by i.l. or i.v. routes. The lesion progression was assessed by its thickness measured by pachymetry. Forty-two days after infection, animals were euthanized and parasite burden in the footpad and in the draining lymph nodes was quantified by the limiting dilution assay (LDA), and spleen cells were phenotyped by flow cytometry. No significant difference was observed in lesion progression, regardless of the MSC route of administration. However, animals treated with i.v. MSCs presented a significant increase in parasite load in comparison with controls. On the other hand, no harmful effect due to MSCs i.l. administered was observed. The spleen cellular profile analysis showed an increase of IL-10 producing T CD4+ and TCD8+ cells in the spleen only in mice treated with i.v. MSC. The excessive production of IL-10 could be associated with the disease-aggravating effects of MSC therapy when intravenously administered. As a conclusion, in the current murine model of L. amazonensis-induced cutaneous disease, MSCs did not control the damage of cutaneous disease and, depending on the administration route, it could result in deleterious effects. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
4. Efficacy of intranasal LaAg vaccine against Leishmania amazonensis infection in partially resistant C57Bl/6 mice.
- Author
-
Silveira Pratti, Juliana Elena, Ramos, Tadeu Diniz, Pereira, Joyce Carvalho, da Fonseca-Martins, Alessandra Marcia, Maciel-Oliveira, Diogo, Oliveira-Silva, Gabriel, de Mello, Mirian França, Chaves, Suzana Passos, Oliveira Gomes, Daniel Claudio, Diaz, Bruno Lourenço, Rossi-Bergmann, Bartira, and de Matos Guedes, Herbert Leonel
- Subjects
LEISHMANIASIS vaccines ,ENZYME-linked immunosorbent assay ,INTERLEUKIN-18 ,IMMUNOREGULATION ,LABORATORY mice - Abstract
Background: We have previously demonstrated that intranasal vaccination of highly susceptible BALB/c mice with whole Leishmania amazonensis antigens (LaAg) leads to protection against murine cutaneous leishmaniasis. Here, we evaluate the response of partially resistant C57BL/6 mice to vaccination as a more representative experimental model of human cutaneous leishmaniasis. Methods: C57BL/6 mice from different animal facilities were infected with L. amazonensis (Josefa strain) to establish the profile of infection. Intranasal vaccination was performed before the infection challenge with two doses of 10 μg of LaAg alone or associated with the adjuvant ADDAVAX
® by instillation in the nostrils. The lesion progression was measured with a dial caliper and the parasite load by limited dilution assay in the acute and chronic phases of infection. Cytokines were quantified by ELISA in the homogenates of infected footpads. Results: C57BL/6 mice from different animal facilities presented the same L. amazonensis infection profile, displaying a progressive acute phase followed by a controlled chronic phase. Parasites cultured in M199 and Schneider’s media were equally infective. Intranasal vaccination with LaAg led to milder acute and chronic phases of the disease. The mechanism of protection was associated with increased production of IFN-gamma in the infected tissue as measured in the acute phase. Association with the ADDAVAX® adjuvant did not improve the efficacy of intranasal LaAg vaccination. Rather, ADDAVAX® reduced vaccination efficacy. Conclusion: This study demonstrates that the efficacy of adjuvant-free intranasal vaccination with LaAg is extendable to the more resistant C57Bl/6 mouse model of infection with L. amazonensis, and is thus not exclusive to the susceptible BALB/c model. These results imply that mucosal immunomodulation by LaAg leads to peripheral protection irrespective of the genetic background of the host. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
5. Simvastatin Resistance of Leishmania amazonensis Induces Sterol Remodeling and Cross-Resistance to Sterol Pathway and Serine Protease Inhibitors.
- Author
-
Fujii, Thais Tenorio Soares, Gomes, Pollyanna Stephanie, do Monte-Neto, Rubens Lima, de Oliveira Gomes, Daniel Claudio, Ouellette, Marc, Torres-Santos, Eduardo Caio, Andrade-Neto, Valter Viana, and de Matos Guedes, Herbert Leonel
- Subjects
PROTEASE inhibitors ,SIMVASTATIN ,SERINE proteinase inhibitors ,SERINE ,LEISHMANIA ,KETONES ,ELASTASES - Abstract
The sterol biosynthesis pathway of Leishmania spp. is used as a pharmacological target; however, available information about the mechanisms of the regulation and remodeling of sterol-related genes is scarce. The present study investigated compensatory mechanisms of the sterol biosynthesis pathway using an inhibitor of HMG-CoA reductase (simvastatin) and by developing drug-resistant parasites to evaluate the impact on sterol remodeling, cross-resistance, and gene expression. Simvastatin-resistant L. amazonensis parasites (LaSimR) underwent reprogramming of sterol metabolism manifested as an increase in cholestane- and stigmastane-based sterols and a decrease in ergostane-based sterols. The levels of the transcripts of sterol 24-C-methyltransferase (SMT), sterol C14-α-demethylase (C14DM), and protease subtilisin (SUB) were increased in LaSimR. LaSimR was cross-resistance to ketoconazole (a C14DM inhibitor) and remained sensitive to terbinafine (an inhibitor of squalene monooxygenase). Sensitivity of the LaSimR mutant to other antileishmanial drugs unrelated to the sterol biosynthesis pathway, such as trivalent antimony and pentamidine, was similar to that of the wild-type strain; however, LaSimR was cross-resistant to miltefosine, general serine protease inhibitor N-p-tosyl-l-phenylalanine chloromethyl ketone (TPCK), subtilisin-specific inhibitor 4-[(diethylamino)methyl]-N-[2-(2-methoxyphenyl)ethyl]-N-(3R)-3-pyrrolidinyl-benzamide dihydrochloride (PF-429242), and tunicamycin. The findings on the regulation of the sterol pathway can support the development of drugs and protease inhibitors targeting this route in parasites. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
6. Immunomodulating role of IL-10-producing B cells in Leishmania amazonensis infection.
- Author
-
Firmino-Cruz, Luan, Ramos, Tadeu Diniz, da Fonseca-Martins, Alessandra Marcia, Maciel-Oliveira, Diogo, Oliveira-Silva, Gabriel, Pratti, Juliana Elena Silveira, Cavazzoni, Cecília, Chaves, Suzana Passos, Oliveira Gomes, Daniel Claudio, Morrot, Alexandre, Freire-de-Lima, Leonardo, Vale, André M., Freire-de-Lima, Celio Geraldo, Decote-Ricardo, Debora, and de Matos Guedes, Herbert Leonel
- Subjects
- *
B cells , *LEISHMANIA , *SERUM , *IMMUNOREGULATION , *LYMPH nodes - Abstract
Highlights • Leishmania amazonensis infection induced IL-10 production by follicular B cells. • Infected Xid mice had delayed lesion growth and lower levels of IL-10 production than WT. • Infected Xid presented lower number of total follicular B cells than WT. • Infected Xid mice presented lower levels of serum IgM, IgG. IgG1, IgG2a and IgG2b antibodies. • Infected Xid exhibited similar production of IL-10 by T Cells but less by B cells. Abstract This work aims to study the immunomodulation of B lymphocytes during L. amazonensis infection. We demonstrated in this study that follicular B cells from draining lymph nodes of infected wild type BALB/c mice are the major source of IL-10 during infection. We infected BALB/Xid mice that developed smaller lesions in comparison with the control, but the parasite load obtained from the infected tissues was similar in both groups. We observed a reduction in the number of follicular B cells from BALB/Xid mice in relation to WT mice and, consequently, lower levels of IgM, IgG, IgG1, IgG2a and IgG2b in the serum of BALB/Xid when compared with wild type mice. BALB/Xid mice also presented lower levels of IL-10 in the infected footpad, draining lymph nodes and in the spleen when compared with WT infected tissues. We did not detect differences in the number of IL-10 producing CD4+ and CD8+ T cells between WT and BALB/Xid mice; however, a strong reduction of IL-10 producing follicular B cells was noted in BALB/Xid mice. When analyzed together, our data indicate that B cells are related with lesion pathogenesis through the production of antibodies and IL-10. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.